{"id":"https://openalex.org/W4400977182","doi":"https://doi.org/10.1097/yic.0000000000000563","title":"The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults","display_name":"The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults","publication_year":2024,"publication_date":"2024-07-22","ids":{"openalex":"https://openalex.org/W4400977182","doi":"https://doi.org/10.1097/yic.0000000000000563","pmid":"https://pubmed.ncbi.nlm.nih.gov/39052354","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12122092"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0000000000000563","doi":"https://doi.org/10.1097/yic.0000000000000563","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000563","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/yic.0000000000000563","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013970045","display_name":"Leslie Citrome","orcid":"https://orcid.org/0000-0002-6098-9266","observed_orcids":["https://orcid.org/0000-0002-6098-9266"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Citrome","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066277838","display_name":"Elena \u00c1lvarez\u2010Bar\u00f3n","orcid":"https://orcid.org/0009-0009-1288-5743","observed_orcids":["https://orcid.org/0009-0009-1288-5743"]},"institutions":[{"id":"https://openalex.org/I4210159862","display_name":"Angelini Pharma (Italy)","ror":"https://ror.org/05bz49965","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210159862"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena \u00c1lvarez-Bar\u00f3n","raw_affiliation_strings":["Angelini Pharma S.p.a, Global Medical Department, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Angelini Pharma S.p.a, Global Medical Department, Rome, Italy","institution_ids":["https://openalex.org/I4210159862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031703636","display_name":"Irene Gabarda-Inat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159862","display_name":"Angelini Pharma (Italy)","ror":"https://ror.org/05bz49965","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210159862"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Irene Gabarda-Inat","raw_affiliation_strings":["Angelini Pharma S.p.a, Global Medical Department, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Angelini Pharma S.p.a, Global Medical Department, Rome, Italy","institution_ids":["https://openalex.org/I4210159862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104209963","display_name":"Karthinathan Thangavelu","orcid":"https://orcid.org/0000-0001-9449-2330","observed_orcids":["https://orcid.org/0000-0001-9449-2330"]},"institutions":[{"id":"https://openalex.org/I4210133698","display_name":"National Institute of Statistics","ror":"https://ror.org/03ftrk873","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210133698"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Karthinathan Thangavelu","raw_affiliation_strings":["Statistics Department, Medastats, LLC, Tampa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics Department, Medastats, LLC, Tampa","institution_ids":["https://openalex.org/I4210133698"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006081848","display_name":"Michael Tocco","orcid":"https://orcid.org/0000-0003-1474-6666","observed_orcids":["https://orcid.org/0000-0003-1474-6666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Tocco","raw_affiliation_strings":["Medical Department, Sumitomo Pharma America, Inc., Marlborough, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Sumitomo Pharma America, Inc., Marlborough, Massachusetts, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031703636"],"corresponding_institution_ids":["https://openalex.org/I4210159862"],"apc_list":null,"apc_paid":null,"fwci":0.7094,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.70002267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"40","issue":"4","first_page":"214","last_page":"223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/hostility","display_name":"hostility","score":0.8960000276565552},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6790000200271606},{"id":"https://openalex.org/keywords/acute-exacerbation","display_name":"acute exacerbation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9160000085830688},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.6290000081062317},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.7580000162124634},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.8230000138282776},{"id":"https://openalex.org/keywords/early-onset-schizophrenia","display_name":"early-onset schizophrenia","score":0.9039999842643738},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2781214261","wikidata":"https://www.wikidata.org/wiki/Q2729863","display_name":"Hostility","level":2,"score":0.9061623215675354},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.8776355385780334},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6276929378509521},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.5799485445022583},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.5392815470695496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5037197470664978},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48011350631713867},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.46750980615615845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.428554505109787},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4276649057865143},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.41165101528167725},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40374454855918884},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.36033034324645996},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.34891244769096375},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069056","descriptor_name":"Lurasidone Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006791","descriptor_name":"Hostility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/yic.0000000000000563","doi":"https://doi.org/10.1097/yic.0000000000000563","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000563","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12122092","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12122092","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12122092/pdf/icp-40-214.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int Clin Psychopharmacol","raw_type":"Text"},{"id":"pmid:39052354","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39052354","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/yic.0000000000000563","doi":"https://doi.org/10.1097/yic.0000000000000563","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000563","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323946","display_name":"Angelini Pharma","ror":"https://ror.org/05bz49965"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400977182.pdf","grobid_xml":"https://content.openalex.org/works/W4400977182.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1600351710","https://openalex.org/W1866173351","https://openalex.org/W1966050988","https://openalex.org/W1974729024","https://openalex.org/W1977496000","https://openalex.org/W1979797229","https://openalex.org/W1979819977","https://openalex.org/W1980143549","https://openalex.org/W1981740077","https://openalex.org/W1986011584","https://openalex.org/W1988775970","https://openalex.org/W1991916074","https://openalex.org/W1995601667","https://openalex.org/W1996014577","https://openalex.org/W1997606519","https://openalex.org/W1997910708","https://openalex.org/W1998767273","https://openalex.org/W2003713069","https://openalex.org/W2005834636","https://openalex.org/W2020642999","https://openalex.org/W2038179898","https://openalex.org/W2039404912","https://openalex.org/W2042589377","https://openalex.org/W2046420174","https://openalex.org/W2048731347","https://openalex.org/W2070893229","https://openalex.org/W2074371523","https://openalex.org/W2077138902","https://openalex.org/W2100557888","https://openalex.org/W2104487123","https://openalex.org/W2108258567","https://openalex.org/W2118451279","https://openalex.org/W2119527374","https://openalex.org/W2137044087","https://openalex.org/W2147322097","https://openalex.org/W2166033924","https://openalex.org/W2183006426","https://openalex.org/W2262339371","https://openalex.org/W2274260754","https://openalex.org/W2414713280","https://openalex.org/W2611763644","https://openalex.org/W2772157607","https://openalex.org/W2957311488","https://openalex.org/W2981764141","https://openalex.org/W2982167270","https://openalex.org/W3093032938","https://openalex.org/W3118579902"],"related_works":["https://openalex.org/W2431706385","https://openalex.org/W4405636332","https://openalex.org/W4390241718","https://openalex.org/W2611615510","https://openalex.org/W1972191812","https://openalex.org/W2062889524","https://openalex.org/W1866173351","https://openalex.org/W2262339371","https://openalex.org/W3118579902","https://openalex.org/W4405636177"],"abstract_inverted_index":{"Symptoms":[0],"of":[1,8,27,43,65,91,114],"hostility":[2,47,111,140,146,189],"in":[3,48,97,109,145,156,195],"patients":[4,49,73,99],"during":[5],"acute":[6],"exacerbations":[7],"schizophrenia":[9],"have":[10,22],"been":[11],"associated":[12],"with":[13,50,136,152],"aggressive":[14],"behavior.":[15],"Data":[16],"suggest":[17,200],"that":[18,201],"some":[19],"second-generation":[20],"antipsychotics":[21],"specific":[23],"anti-hostility":[24,206],"effects,":[25],"independent":[26],"sedation":[28],"and":[29,86,117,132,174,194],"positive":[30,129],"symptom":[31,130],"improvement.":[32],"Two":[33],"post":[34],"hoc":[35],"analyses":[36],"were":[37,126],"performed":[38],"to":[39,75],"examine":[40],"the":[41,83,110,115,186,196],"efficacy":[42],"lurasidone":[44,66,92,161,202],"for":[45,128,149,185],"reducing":[46],"schizophrenia.":[51],"One":[52],"analysis":[53,70],"pooled":[54,71],"adults":[55,135],"(":[56],"N":[57,79],"=":[58,80,164,168,172,177],"1168)":[59],"from":[60,82],"5":[61],"placebo-controlled,":[62],"6-week":[63],"trials":[64],"(40-160":[67],"mg).":[68],"Another":[69],"younger":[72],"(up":[74],"age":[76],"25":[77],"years,":[78],"427)":[81],"adult":[84],"studies":[85],"a":[87,137,153],"similarly":[88],"designed":[89],"trial":[90],"(40":[93],"or":[94],"80":[95,166],"mg)":[96],"adolescent":[98],"(13-17":[100],"years":[101],"old).":[102],"The":[103,179],"outcome":[104],"measure":[105],"was":[106,147,183],"mean":[107],"change":[108,131],"item":[112],"(P7)":[113],"Positive":[116],"Negative":[118],"Syndrome":[119],"Scale":[120],"(PANSS).":[121],"To":[122],"address":[123],"pseudospecificity,":[124],"results":[125],"adjusted":[127],"sedation.":[133],"In":[134],"baseline":[138],"PANSS":[139],"score":[141],"\u22652,":[142],"significant":[143],"improvement":[144],"observed":[148,184],"all":[150],"doses":[151],"dose-related":[154,205],"increase":[155],"effect":[157],"size":[158],"(Cohen's":[159],"d):":[160],"40":[162],"mg":[163,167,171,176],"0.18,":[165],"0.24,":[169],"120":[170],"0.36,":[173],"160":[175],"0.53.":[178],"same":[180],"dose-response":[181],"pattern":[182],"more":[187],"severe":[188],"subgroups":[190],"(P7:":[191],"\u22653,":[192],"\u22654),":[193],"early-onset":[197],"population.":[198],"Results":[199],"has":[203],"specific,":[204],"effects.":[207]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-26T00:00:00"}